HighTower Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12M | Buy |
70,904
+385
| +0.5% | +$65.8K | 0.01% | 807 |
|
|
2025
Q4 | $11.9M | Buy |
70,519
+18,479
| +36% | +$3M | 0.01% | 792 |
|
|
2025
Q3 | $7.51M | Buy |
52,040
+333
| +0.6% | +$45.5K | 0.01% | 970 |
|
|
2025
Q2 | $6.54M | Sell |
51,707
-5,142
| -9% | -$631K | 0.01% | 985 |
|
|
2025
Q1 | $7.27M | Sell |
56,849
-27,095
| -32% | -$3.67M | 0.01% | 898 |
|
|
2024
Q4 | $11.1M | Buy |
83,944
+4,047
| +5% | +$569K | 0.02% | 714 |
|
|
2024
Q3 | $11.6M | Sell |
79,897
-734
| -0.9% | -$106K | 0.02% | 696 |
|
|
2024
Q2 | $11.1M | Sell |
80,631
-6,816
| -8% | -$910K | 0.02% | 682 |
|
|
2024
Q1 | $12M | Sell |
87,447
-4,196
| -5% | -$573K | 0.02% | 630 |
|
|
2023
Q4 | $12.4M | Buy |
91,643
+14,900
| +19% | +$1.82M | 0.02% | 620 |
|
|
2023
Q3 | $9.35M | Sell |
76,743
-1,204
| -2% | -$153K | 0.02% | 690 |
|
|
2023
Q2 | $9.9M | Sell |
77,947
-3,218
| -4% | -$418K | 0.02% | 651 |
|
|
2023
Q1 | $10.5M | Sell |
81,165
-1,604
| -2% | -$210K | 0.02% | 612 |
|
|
2022
Q4 | $10.9M | Buy |
82,769
+4,342
| +6% | +$561K | 0.02% | 584 |
|
|
2022
Q3 | $9.18M | Sell |
78,427
-3,891
| -5% | -$483K | 0.02% | 598 |
|
|
2022
Q2 | $9.69M | Sell |
82,318
-1,740
| -2% | -$207K | 0.03% | 580 |
|
|
2022
Q1 | $11M | Buy |
84,058
+12,178
| +17% | +$1.59M | 0.02% | 581 |
|
|
2021
Q4 | $11M | Buy |
71,880
+5,626
| +8% | +$871K | 0.02% | 576 |
|
|
2021
Q3 | $10.7M | Buy |
66,254
+1,224
| +2% | +$206K | 0.03% | 511 |
|
|
2021
Q2 | $10.6M | Buy |
65,030
+2,404
| +4% | +$370K | 0.03% | 496 |
|
|
2021
Q1 | $9.42M | Sell |
62,626
-3,379
| -5% | -$537K | 0.03% | 504 |
|
|
2020
Q4 | $9.99M | Sell |
66,005
-610
| -0.9% | -$87.2K | 0.04% | 374 |
|
|
2020
Q3 | $9M | Buy |
66,615
+2,127
| +3% | +$289K | 0.04% | 372 |
|
|
2020
Q2 | $8.82M | Buy |
64,488
+6,663
| +12% | +$849K | 0.05% | 354 |
|
|
2020
Q1 | $6.23M | Sell |
57,825
-531
| -0.9% | -$61.1K | 0.04% | 390 |
|
|
2019
Q4 | $7.02M | Sell |
58,356
-917
| -2% | -$102K | 0.04% | 436 |
|
|
2019
Q3 | $5.89M | Sell |
59,273
-1,908
| -3% | -$200K | 0.03% | 492 |
|
|
2019
Q2 | $6.67M | Sell |
61,181
-54,731
| -47% | -$5.82M | 0.04% | 461 |
|
|
2019
Q1 | $13M | Buy |
115,912
+57,409
| +98% | +$6.3M | 0.09% | 249 |
|
|
2018
Q4 | $5.63M | Buy |
58,503
+180
| +0.3% | +$19.1K | 0.04% | 425 |
|
|
2018
Q3 | $7.11M | Buy |
58,323
+202
| +0.3% | +$23.8K | 0.05% | 395 |
|
|
2018
Q2 | $6.38M | Sell |
58,121
-6,491
| -10% | -$694K | 0.05% | 419 |
|
|
2018
Q1 | $6.91M | Sell |
64,612
-11,812
| -15% | -$1.31M | 0.06% | 364 |
|
|
2017
Q4 | $8.16M | Sell |
76,424
-766
| -1% | -$81.9K | 0.07% | 316 |
|
|
2017
Q3 | $8.58M | Sell |
77,190
-5,841
| -7% | -$624K | 0.07% | 294 |
|
|
2017
Q2 | $8.6M | Sell |
83,031
-1,641
| -2% | -$162K | 0.08% | 287 |
|
|
2017
Q1 | $8.27M | Buy |
84,672
+19,287
| +29% | +$1.85M | 0.08% | 271 |
|
|
2016
Q4 | $5.79M | Buy |
65,385
+13,272
| +25% | +$1.21M | 0.06% | 339 |
|
|
2016
Q3 | $5.02M | Buy |
52,113
+1,944
| +4% | +$185K | 0.06% | 354 |
|
|
2016
Q2 | $4.32M | Sell |
50,169
-33,030
| -40% | -$2.96M | 0.05% | 374 |
|
|
2016
Q1 | $7.24M | Buy |
83,199
+6,681
| +9% | +$597K | 0.02% | 276 |
|
|
2015
Q4 | $8.62M | Buy |
76,518
+18,744
| +32% | +$2.03M | 0.1% | 211 |
|
|
2015
Q3 | $5.85M | Buy |
57,774
+14,421
| +33% | +$1.73M | 0.08% | 280 |
|
|
2015
Q2 | $5.33M | Sell |
43,353
-61,464
| -59% | -$7.36M | 0.09% | 256 |
|
|
2015
Q1 | $12M | Buy |
104,817
+66,339
| +172% | +$7.32M | 0.18% | 128 |
|
|
2014
Q4 | $3.89M | Buy |
38,478
+7,755
| +25% | +$754K | 0.06% | 343 |
|
|
2014
Q3 | $2.8M | Buy |
30,723
+324
| +1% | +$28.4K | 0.05% | 434 |
|
|
2014
Q2 | $2.6M | Sell |
30,399
-2,682
| -8% | -$211K | 0.05% | 482 |
|
|
2014
Q1 | $2.61M | Sell |
33,081
-14,907
| -31% | -$1.24M | 0.05% | 430 |
|
|
2013
Q4 | $3.63M | Sell |
47,988
-5,088
| -10% | -$361K | 0.07% | 294 |
|
|
2013
Q3 | $3.71M | Buy |
53,076
+15,864
| +43% | +$1.04M | 0.09% | 242 |
|
|
2013
Q2 | $2.16M | Buy |
+37,212
| New | +$2.15M | 0.06% | 371 |
|
Other funds holding IBB
CB
HighTower Advisors's IBB Position: Q1 2026 in Review
HighTower Advisors increased its iShares Biotechnology ETF (IBB) stake by 0.55% in Q1 2026, buying an estimated $65.8K and bringing the position to 70,904 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #807.
HighTower Advisors first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $13M in Q1 2019. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- HighTower Advisors held 70,904 shares of iShares Biotechnology ETF worth $12M as of Q1 2026.
- HighTower Advisors bought 385 iShares Biotechnology ETF shares in Q1 2026, an estimated $65.8K.
- iShares Biotechnology ETF made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #807 holding.
- HighTower Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
- HighTower Advisors's iShares Biotechnology ETF position peaked at $13M in Q1 2019.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.